Why we can't trust clinical guidelines

BMJ (Online)

Volumn 346, Issue 7913, 2013, Pages

  Lenzer, Jeanne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; DROSPIRENONE; STEROID;

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DRUG MANUFACTURE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL LITERATURE; NEUROSURGEON; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLISHING; SPINAL CORD INJURY;

EID: 84879332852     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f3830     Document Type: Article

References (39)

1. Cundiff D. The story behind a whistleblower doctor license reinstatement hearing. KevinMD.com, 6 January 2010. www.kevinmd.com/blog/2010/01/story- whistleblower-doctor-license-reinstatement-hearing.html.
2. Garber AM. Evidence-based guidelines as a foundation for performance incentives. Health Aff (Millwood) 2005;24:174-9. (Pubitemid 40169785)
3. Timmermans S, Mauck A. The promises and pitfalls of evidence-based medicine. Health Aff (Millwood) 2005;24:18-28. (Pubitemid 40169771)
4. Molloy S, Middleton F, Casey AT. Failure to administer methylprednisolone for acute traumatic spinal cord injury - a prospective audit of 100 patients from a regional spinal injuries unit. Injury 2002;33:575-8.
5. Lenzer J. NIH secrets: study break. New Republic 2006 Oct 6. www.newrepublic.com/article/national-institutes-health-fred-geisler-spinal-cord.
6. Canadian Association of Emergency Physicians. Steroids in acute spinal cord injury. CJEM 2003;5:7-9.
7. Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev 2009;1:CD001046.
8. Bracken M, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med 1990;323:1207-9.
9. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 1998;45:1088-93. (Pubitemid 29004125)
10. Coleman WP, Benzel D, Cahill DW, Ducker T, Geisler F, Green B, et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 2000;13:185-99. (Pubitemid 32201543)
11. Hurlbert RJ, Hadley MN, Walters BC, Aarabi B, Dhall SS, Gelb DE, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 2013;72:93-105.
12. Kung J. Failure of clinical practice guidelines to meet institute of medicine standards: two more decades of little, if any, progress. Arch Intern Med 2012;172:1628-33.
13. Lenzer J, Epstein K. The Yaz men. Washington Monthly 2012 Jan 9. www.washingtonmonthly.com/ten-miles-square/2012/01/the-yaz-men-members-of-fda- pan034651.php.
14. Institute of Medicine. Clinical practice guidelines we can trust. National Academies Press, 2011.
15. Ransohoff DF, Pignone M, Sox HC. How to decide whether a clinical practice guideline is trustworthy. JAMA 2013;309:139-40.
16. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 2010;152:738-41.
17. Gale EA. Conflicts of interest in guideline panel members. BMJ 2011;343:d5728.
18. Clinical policy: use of intravenous tPA for the management of acute ischemic stroke in the emergency department. Ann Emerg Med 2013;61:225-43.
19. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.
20. Poll on support for new guidelines on tPA for stroke. SurveyMonkey 2013. www.surveymonkey.com/s/CBF2ZDB.
21. Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the Increasing Stroke Treatment through Interactive behavioral Change Tactic (INSTINCT) Trial hospitals. Stroke 2010;41:2026-32.
22. Fatovich DM. Believing is seeing: stroke thrombolysis remains unproven after the third international stroke trial (IST-3). Emerg Med Australas 2012;24:477-9.
23. Hoffman JR, Cooper RJ. How is more negative evidence being used to support claims of benefit: the curious case of the third international stroke trial (IST-3). Emerg Med Australas 2012;24:473-6.
24. Hoffman JR, Schriger DL. A graphic reanalysis of the NINDS Trial. Ann Emerg Med 2009;54:329-36.
25. Klauer K. History repeating: questioning tPA. Emerg Physicians Monthly, 2012 Nov. www.epmonthly.com/columns/in-my-opinion/history-repeating-questioning- tpa/.
26. Newman D. The guideline, the science, and the gap. Scientific medicine and research translation.17 April 2013. http://smartem.org/content/guideline- science-and-gap.
27. Newman DH, Shreves AE. Thrombolysis in acute ischaemic stroke. Lancet 2012;380:1053-4; author reply 1054-5.
28. National Institute of Neurological Disorders. Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
29. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. BMJ 2002;324:723-9.
30. Kolata G. Lost chances for survival, before and after stroke. New York Times 2007 May 28. www.nytimes.com/2007/05/28/health/28stroke.html.
31. Radecki RP. Skepticism about thrombolytics in stroke is not unreasonable. Nat Rev Neurol 2011;8:176.
32. Fatovich DM. Response to the recent best evidence topic on the use of thrombolysis in stroke. Emerg Med J 2012;29:82.
33. Newman D. Thrombolytics for acute ischemic stroke. TheNNT.com 2012. www.thennt.com/nnt/thrombolytics-for-stroke/.
34. Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med 2005;46:56-60. (Pubitemid 40916897)
35. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009;4:CD000213.
36. Sloane EP. Clinical Use of tPA in acute ischemic stroke. www.uic.edu/com/ferne/pdf/chile1103/sloantpa-acep-chile1103-lecture.pdf.
37. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-98. (Pubitemid 44749317)
38. Armstrong D. Medical journal spikes article on industry ties of kidney group. Wall Street Journal 2006 Dec 26. http://online.wsj.com/article/ SB116709354076459273.html.
39. Abramson JE, Barnard RJ, Barry HC, Bezruchka S, Brody H, Brown DL, et al. Epetition to the National Institutes of Health seeking and independent review panel to re-evaluate the national cholesterol education project guidelines. 2004. http://cspinet.org/new/pdf/finalnihltr.pdf.